Citation map · Study

SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus‐1, hepatitis C virus, and hepatitis B virus

5 references·16 citing·31 second hop

FromToDepth

this work references cited by second hop

References

1996The Risk of Transfusion-Transmitted Viral Infections1,865 cited
2004Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing535 cited
2005A new strategy for estimating risks of transfusion‐transmitted viral infections based on rates of detection of recently infected donors426 cited
2003The cost‐effectiveness of NAT for HIV, HCV, and HBV in whole‐blood donations264 cited
1999Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting254 cited

Cited by

2009Experience of mandatory nucleic acid test (NAT) screening across all blood organizations in Germany: NAT yield versus breakthrough transmissions73 cited
2019History and Future of Nucleic Acid Amplification Technology Blood Donor Testing64 cited
2013Nucleic acid testing for blood banks: An experience from a tertiary care centre in New Delhi, India56 cited
2018False positive viral marker results in blood donors and their unintended consequences43 cited
2012Trends in prevalence, incidence, and residual risk of major transfusion‐transmissible viral infections in United Arab Emirates blood donors: impact of individual‐donation nucleic acid testing, 2004 through 200936 cited
2015Individual donor-nucleic acid testing for human immunodeficiency virus-1, hepatitis C virus and hepatitis B virus and its role in blood safety35 cited
2013Undisclosed human immunodeficiency virus risk factors identified through a computer‐based questionnaire program among blood donors in B razil

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

34 cited

2013How safe is safe: new human immunodeficiency virus Type 1 variants missed by nucleic acid testing30 cited

2015Impact of nucleic acid amplification test on screening of blood donors in Northern Pakistan29 cited

2013Six-year pilot study on nucleic acid testing for blood donations in China23 cited

2009Blood donor screening with cobas s 201/cobas TaqScreen MPX under routine conditions at German Red Cross institutes22 cited

2014Estimating the residual risk for HIV , HCV and HBV in different types of platelet concentrates in Germany20 cited

2014Estimating window period blood donations for human immunodeficiency virus T ype 1, hepatitis C virus, and hepatitis B virus by nucleic acid amplification testing in Southern P akistan19 cited

2012Sufficient blood, safe blood: can we have both?18 cited

2014Factors in enhancing blood safety by nucleic acid technology testing for human immunodeficiency virus, hepatitis C virus and hepatitis B virus17 cited

2018IMPACT OF MULTIPLEX PCR IN REDUCING THE RISK OF RESIDUAL TRANSFUSION-TRANSMITTED HUMAN IMMUNODEFICIENCY AND HEPATITIS B AND C VIRUSES IN BURKINA FASO17 cited